Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zhaoke (guangzhou) Ophthalmology Pharmaceutical Ltd.

Clinical trials sponsored by Zhaoke (guangzhou) Ophthalmology Pharmaceutical Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could eye drops replace injections for a leading cause of blindness? Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Could eye drops replace injections for a leading cause of blindness?

Knowledge-focused Not yet recruiting

This early-stage trial is evaluating the safety, tolerability, and how the body absorbs PAN-90806, an experimental eye drop being developed for wet age-related macular degeneration (AMD), a leading cause of vision loss. Healthy adults aged 18 to 50 will receive either PAN-90806 o…

Phase 1 • Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. • Aim: Knowledge-focused

Last updated Aug 16, 2026 00:00 UTC